Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 3Neoplasms 2Stroke 1Sarcoma, Alveolar Soft Part 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neuralgia 1Myocardial Infarction 1Liver Neoplasms 1Liver Cirrhosis 1Hot Flashes 1Hemorrhage 1Hand-Foot Syndrome 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cholecalciferol 4Nutrition Assessment 3Exercise 3Blood Pressure 3Atorvastatin 3acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Vitamin E 2Vitamin D 2Rosuvastatin Calcium 2Methods 2Metformin 2Gonadotropin-Releasing Hormone 2Geritol 2Fish Oils 2Fatty Acids, Omega-3 2Ethanol 2Educational Status 2Diet, Mediterranean 2Aspirin 2xinmailong 1sofosbuvir-velpatasvir drug combination 1pembrolizumab 1palbociclib 1ficlatuzumab 1beta Carotene 1amlodipine, atorvastatin drug combination 1Vorinostat 1Vitamin B 6 1Vitamin B 12 1Tumor Necrosis Factor Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cardiovascular Diseases × Vitamin B 6 × Clear all
NCT00106886 2005-09-20

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

McMaster University

Phase 4 Unknown
5,000 enrolled

Cardiovascular Diseases, Myocardial Infarction, Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡